Chasing Wellness: Gilead’s Remdesivir & Tools for Healthy Isolation

Squawk Pod

CNBC

Business News, News, Investing, Business

4.2 • 543 Ratings

🗓️ 29 April 2020

⏱️ 27 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

A new study from the NIAID revealed that at least 50% of Covid-19 patients treated with a 5-day dosage of Gilead’s Remdesivir reported improved symptoms and were discharged from the hospital within two weeks. Former FDA Commissioner Dr. Scott Gottlieb describes the treatment as “part of a better toolbox” for fighting the coronavirus, but “not a home run.” Plus, Mindy Grossman, CEO of WW International, (formerly known as Weight Watchers) discusses keeping her business and our bodies well during quarantine.

Transcript

Click on a timestamp to play from that location

0:00.0	This is going to be Squawk Pod. I'm C. NBC producer Katie Kramer today on our podcast.
0:05.1	Possibly game-changing news from Gilead on a COVID drug trial for Remdesifir.
0:10.4	It's not going to be a home run, it's not going to be a cure, but it is going to be a drug potentially. Former F2. of well into 2021 in terms of having a vaccine available in the hundreds of
0:24.0	millions of doses that you would need to mass inoculate a population.
0:27.0	Plus feeling too close to your fridge. A lot of Americans, including Joe
0:31.6	Kernan, are with you the CEO of W.W.
0:34.1	Formerly known as Weight Watchers on Managing Wellness and Business during quarantine.
0:39.0	We are definitely seeing a shift right now, and we believe that coming out of this health and wellness is not
0:45.6	going to be a luxury it's going to be a necessity. It's Wednesday April 29th
0:49.8	2020 Squawk Pie begins right now. Good morning everybody welcome to Squawk Pie begins right now.
0:53.4	Good morning everybody.
0:54.4	Welcome to Squawk Box here on C.
0:56.4	I'm Becky Quick, along with Joe Kernan and Andrew Ross Sorkin.
0:59.2	We've been watching the website.
1:01.3	First up on today's podcast, an update on the coronavirus pandemic and the race for a vaccine
1:06.4	COVID-19 cases in the US have now topped 1 million and with each new diagnosis
1:11.8	the urgency for drug development increases.
1:14.7	We were joined on Squackbox early this morning by Dr. Scott Gottlie, former FDA Commissioner
1:19.1	and Board Member at Pfizer and Illumina.
1:22.1	This turned out to be the first of two conversations we had
1:24.6	with Scott today.
1:25.6	I think in terms of having a vaccine available at scale, you know, I don't know the
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from CNBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of CNBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.